Search Results - "Farnham, D J"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Once-daily pravastatin in patients with primary hypercholesterolemia: a dose-response study by Jones, P H, Farmer, J A, Cressman, M D, McKenney, J M, Wright, J T, Proctor, J D, Berkson, D M, Farnham, D J, Wolfson, P M, Colfer, H T

    Published in Clinical cardiology (Mahwah, N.J.) (01-02-1991)
    “…This multicenter, double-blind, placebo-controlled study was conducted to evaluate dose-response effects and safety of once-daily administration of…”
    Get more information
    Journal Article
  2. 2

    Antihypertensive and metabolic effects of single and combined atenolol regimens by Chrysant, S G, Chappel, C, Farnham, D J, Levin, B, Lueg, M, McCluskey, D, Steiner, C

    Published in Journal of clinical pharmacology (01-01-1992)
    “…The antihypertensive and metabolic effects of placebo (PL), a fixed combination of hydrochlorothiazide (25 mg) and triamterene (50 mg) (HCTZ/TRI), atenolol (25…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Underestimation of true pulmonary blood volume by the pulmonary artery wedge injection technique in cardiac patients by Schreiner, B F, Farnham, D J, Logan, D C

    Published in Cardiovascular research (01-01-1978)
    “…Pulmonary blood volume measurements were made comparing pulmonary artery with pulmonary artery wedge and left atrial dye dilution curves in 32 patients with…”
    Get more information
    Journal Article
  5. 5

    A multicenter dose-response study of pirmenol hydrochloride in patients with ventricular premature contractions by Farnham, D.John

    Published in The American journal of cardiology (15-06-1987)
    “…The efficacy of pirmenol in suppressing ventricular premature complexes (VPCs) was assessed in 196 patients in a placebo-controlled, double-blind, multicenter…”
    Get full text
    Journal Article
  6. 6

    Effectiveness of bevantolol in the treatment of angina--a placebo-controlled study by Farnham, D J

    Published in Angiology (01-03-1986)
    “…The antianginal efficacy and safety of bevantolol was compared with placebo in 107 patients with angina pectoris of effort. The median frequency of angina…”
    Get more information
    Journal Article
  7. 7

    Combination propranolol and bepridil therapy in stable angina pectoris by Frishman, William H., Charlap, Shlomo, Farnham, D.John, Sawin, Henry S., Michelson, Eric L., Crawford, Michael H., DiBianco, Robert, Kostis, John B., Zellner, Stephen R., Michie, David D., Katz, Richard J., Mohiuddin, Syed M., Thadani, Udho

    Published in The American journal of cardiology (15-03-1985)
    “…The safety and efficacy of bepridil plus propranolol therapy were investigated in a placebo-controlled, parallel-design, double-blind trial in 56 patients who…”
    Get full text
    Journal Article
  8. 8

    Complete correction of double-outlet right ventricle with situs inversus, 1-loop, and 1-malposition (I,L,L) with subaortic VSD and pulmonary stenosis by Stewart, S, Farnham, J D, Schreiner, B, Manning, J

    “…The repair a unique case of double-outlet right ventricle is reported. This case illustrates the increasingly difficult problem of developing an appropriate…”
    Get more information
    Journal Article
  9. 9

    Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study by Moyé, L A, Pfeffer, M A, Wun, C C, Davis, B R, Geltman, E, Hayes, D, Farnham, D J, Randall, O S, Dinh, H, Arnold, J M

    Published in European heart journal (01-05-1994)
    “…The Survival and Ventricular Enlargement (SAVE) Study demonstrated that long-term administration of the angiotensin-converting enzyme inhibitor captopril to…”
    Get more information
    Journal Article
  10. 10

    Effect of Extended-Release Isosorbide Mononitrate One Hour After Dosing in Patients With Stable Angina Pectoris by Glasser, Stephen P.

    Published in The American journal of cardiology (15-12-1997)
    “…The effect of extended-release isosorbide mononitrate (ER-ISMN) on exercise tolerance 1 hour after dosing was compared with that of placebo in a multicenter,…”
    Get full text
    Journal Article